Knockdown of USP5 (#1) led to significant decrease in tumor growth rate of OVCAR3-derived xenografts at the interval between Day 21 and Day 33 after cell transplantation (Figure 3E, P<0.001). The gene discussed is USP5; the disease is neoplasm.